Dimensional Fund Advisors
CORT icon

Dimensional Fund Advisors’s Corcept Therapeutics CORT Stock Holding History

Dimensional Fund Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.6M Sell
1,553,135
-67,198
-4% -$2.51M 0.01% 1380
2025
Q4 		$56.6M Sell
1,620,333
-272,115
-14% -$21.4M 0.01% 1439
2025
Q3 		$157M Sell
1,892,448
-193,069
-9% -$14M 0.03% 718
2025
Q2 		$153M Sell
2,085,517
-50,993
-2% -$3.7M 0.04% 692
2025
Q1 		$244M Buy
2,136,510
+57,942
+3% +$3.53M 0.06% 362
2024
Q4 		$105M Sell
2,078,568
-453,931
-18% -$23.8M 0.03% 984
2024
Q3 		$117M Sell
2,532,499
-143,836
-5% -$5.11M 0.03% 905
2024
Q2 		$87M Buy
2,676,335
+108,658
+4% +$2.98M 0.02% 1070
2024
Q1 		$64.7M Buy
2,567,677
+257,380
+11% +$6.08M 0.02% 1280
2023
Q4 		$75M Buy
2,310,297
+2,953
+0.1% +$81.1K 0.02% 1139
2023
Q3 		$62.9M Buy
2,307,344
+52,878
+2% +$1.53M 0.02% 1181
2023
Q2 		$50.2M Buy
2,254,466
+100,459
+5% +$2.31M 0.02% 1356
2023
Q1 		$46.7M Buy
2,154,007
+68,382
+3% +$1.5M 0.02% 1376
2022
Q4 		$42.4K Sell
2,085,625
-18,858
-0.9% -$473K 0.01% 1424
2022
Q3 		$54M Buy
2,104,483
+16,811
+0.8% +$450K 0.02% 1162
2022
Q2 		$49.6M Buy
2,087,672
+146,846
+8% +$3.2M 0.02% 1292
2022
Q1 		$43.7M Buy
1,940,826
+57,360
+3% +$1.22M 0.01% 1518
2021
Q4 		$37.3M Sell
1,883,466
-716,179
-28% -$14.5M 0.01% 1616
2021
Q3 		$51.2M Sell
2,599,645
-192,534
-7% -$4.03M 0.02% 1397
2021
Q2 		$61.4M Buy
2,792,179
+179,695
+7% +$4M 0.02% 1267
2021
Q1 		$62.1M Buy
2,612,484
+44,432
+2% +$1.19M 0.02% 1244
2020
Q4 		$67.2M Sell
2,568,052
-31,191
-1% -$657K 0.02% 1110
2020
Q3 		$45.2M Sell
2,599,243
-22,126
-0.8% -$353K 0.02% 1286
2020
Q2 		$44.1M Buy
2,621,369
+50,759
+2% +$713K 0.02% 1307
2020
Q1 		$30.6M Buy
2,570,610
+40,593
+2% +$502K 0.02% 1454
2019
Q4 		$30.6M Sell
2,530,017
-18,670
-0.7% -$260K 0.01% 1806
2019
Q3 		$36M Buy
2,548,687
+38,775
+2% +$476K 0.01% 1660
2019
Q2 		$28M Buy
2,509,912
+203,177
+9% +$2.26M 0.01% 1862
2019
Q1 		$27.1M Buy
2,306,735
+403,699
+21% +$5.02M 0.01% 1886
2018
Q4 		$25.4M Buy
1,903,036
+120,758
+7% +$1.6M 0.01% 1853
2018
Q3 		$25M Buy
1,782,278
+128,416
+8% +$1.79M 0.01% 1986
2018
Q2 		$26M Buy
1,653,862
+77,213
+5% +$1.34M 0.01% 1972
2018
Q1 		$25.9M Buy
1,576,649
+306,691
+24% +$5.68M 0.01% 1905
2017
Q4 		$22.9M Buy
1,269,958
+65,633
+5% +$1.19M 0.01% 1990
2017
Q3 		$23.2M Buy
1,204,325
+355,006
+42% +$5.29M 0.01% 1963
2017
Q2 		$10M Buy
849,319
+386,431
+83% +$4.2M ﹤0.01% 2353
2017
Q1 		$5.07M Buy
462,888
+358,885
+345% +$3.15M ﹤0.01% 2567
2016
Q4 		$755K Buy
+104,003
New +$815K ﹤0.01% 3025
2016
Q2 		– Sell
-10,071
Closed -$47K – 3294
2016
Q1 		$47K Sell
10,071
-89,221
-90% -$348K ﹤0.01% 3264
2015
Q4 		$494K Sell
99,292
-206,608
-68% -$932K ﹤0.01% 3096
2015
Q3 		$1.15M Sell
305,900
-62,779
-17% -$319K ﹤0.01% 2964
2015
Q2 		$2.22M Hold
368,679
– – ﹤0.01% 2828
2015
Q1 		$2.06M Sell
368,679
-14,228
-4% -$51.5K ﹤0.01% 2820
2014
Q4 		$1.15M Hold
382,907
– – ﹤0.01% 2977
2014
Q3 		$1.03M Hold
382,907
– – ﹤0.01% 3004
2014
Q2 		$1.07M Sell
382,907
-4,500
-1% -$13.3K ﹤0.01% 3025
2014
Q1 		$1.69M Hold
387,407
– – ﹤0.01% 2890
2013
Q4 		$1.25M Sell
387,407
-4,200
-1% -$8.49K ﹤0.01% 2980
2013
Q3 		$623K Hold
391,607
– – ﹤0.01% 3146
2013
Q2 		$677K Buy
+391,607
New +$704K ﹤0.01% 3103

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors's CORT Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Corcept Therapeutics (CORT) stake by 4.1% in Q1 2026, selling an estimated $2.51M and leaving 1,553,135 shares worth $62.6M. The position accounts for 0.01% of the portfolio, ranked #1380.

Dimensional Fund Advisors first reported a position in CORT in Q2 2013 and has held it in 50 quarters since. The position peaked at $244M in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Dimensional Fund Advisors held 1,553,135 shares of Corcept Therapeutics worth $62.6M as of Q1 2026.
  • Dimensional Fund Advisors sold 67,198 Corcept Therapeutics shares in Q1 2026, an estimated $2.51M.
  • Corcept Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1380 holding.
  • Dimensional Fund Advisors first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 50 quarters since.
  • Dimensional Fund Advisors's Corcept Therapeutics position peaked at $244M in Q1 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.